Curis | CRIS - Debt


Curis reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 54.6B 17M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Eli Lilly USD 42.5B 3.6M Dec/2025
Exelixis USD 169.54M 3.5M Mar/2026
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Incyte USD 39.43M 982K Mar/2026
Merck USD 49.34B 7.97B Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 20.33B 1.43B Dec/2025
Takeda JPY 4.85T 208B Dec/2025
TG Therapeutics USD 253.71M 8.37M Dec/2025
Verastem USD 66.79M 26.7M Sep/2024
Xoma USD 120.79M 3.27M Jun/2024